Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_assertion description "[The percentage of patients with metastatic disease at a given site was compared between each molecular cohort (EGFR, KRAS, or ALK) and the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_assertion evidence source_evidence_literature NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_assertion SIO_000772 22282022 NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_assertion wasDerivedFrom befree-20140225 NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_assertion wasGeneratedBy ECO_0000203 NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP156796.RA6Iy53iwBv-5veBmcMHRkUOwcJTnVQF4GpBZ_eQhg6lY130_provenance.